{"id":122706,"date":"2025-06-11T08:51:30","date_gmt":"2025-06-11T16:51:30","guid":{"rendered":"https:\/\/xira.com\/p\/2025\/06\/11\/pfizer-scraps-bid-for-depo-provera-mass-tort-following-dismissal-of-most-phila-plaintiffs\/"},"modified":"2025-06-11T08:51:30","modified_gmt":"2025-06-11T16:51:30","slug":"pfizer-scraps-bid-for-depo-provera-mass-tort-following-dismissal-of-most-phila-plaintiffs","status":"publish","type":"post","link":"https:\/\/xira.com\/p\/2025\/06\/11\/pfizer-scraps-bid-for-depo-provera-mass-tort-following-dismissal-of-most-phila-plaintiffs\/","title":{"rendered":"Pfizer Scraps Bid for Depo-Provera Mass Tort Following Dismissal of Most Phila. Plaintiffs"},"content":{"rendered":"<p>While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their claims, that prediction has not come to fruition. Now, there appears to be only a single Depo-Provera lawsuit pending in the Philadelphia Court of Common Pleas.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" align=\"left\" border=\"0\" height=\"1\" width=\"1\" alt=\"\" hspace=\"0\" src=\"https:\/\/feeds.feedblitz.com\/~\/i\/920076839\/0\/law\/legal-news\" title=\"\"><\/p>\n<div><a href=\"https:\/\/feeds.feedblitz.com\/_\/2\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/fbshare20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/28\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/fblike20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/29\/920076839\/law\/legal-news,\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/pinterest20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/12\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/stumble20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/24\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/x.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/20\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/rss20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0\u00a0<\/div>\n<p>While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their claims, that prediction has not come to fruition. Now, there appears to be only a single Depo-Provera lawsuit pending in the Philadelphia Court of Common Pleas.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" align=\"left\" border=\"0\" height=\"1\" width=\"1\" alt=\"\" hspace=\"0\" src=\"https:\/\/feeds.feedblitz.com\/~\/i\/920076839\/0\/law\/legal-news\" title=\"\"><\/p>\n<div><a href=\"https:\/\/feeds.feedblitz.com\/_\/2\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/fbshare20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/28\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/fblike20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/29\/920076839\/law\/legal-news,\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/pinterest20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/12\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/stumble20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/24\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/x.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0<a href=\"https:\/\/feeds.feedblitz.com\/_\/20\/920076839\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img data-recalc-dims=\"1\" width=\"1080\" decoding=\"async\" height=\"20\" src=\"https:\/\/i0.wp.com\/assets.feedblitz.com\/i\/rss20.png?fit=1080%2C20&#038;ssl=1\" alt=\"\" title=\"\"><\/a>\u00a0\u00a0<\/div>\n","protected":false},"excerpt":{"rendered":"<p>While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their claims, that prediction has not come to fruition. Now, there appears to be only a single Depo-Provera lawsuit pending in the Philadelphia Court of Common Pleas. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 While Pfizer said in its petition for [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":122707,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-122706","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-com"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/xira.com\/p\/wp-content\/uploads\/2025\/06\/legal-news-t6lYrB.jpeg?fit=767%2C633&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/122706","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/comments?post=122706"}],"version-history":[{"count":0,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/122706\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media\/122707"}],"wp:attachment":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media?parent=122706"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/categories?post=122706"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/tags?post=122706"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}